{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:20:11Z","timestamp":1789550411945,"version":"build-2803163510"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Plan Nacional de I+D+I of the Ministry of Economy and Competitiveness","award":["BIO2017-82951-R"],"award-info":[{"award-number":["BIO2017-82951-R"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0241780","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T19:00:37Z","timestamp":1604430037000},"page":"e0241780","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae"],"prefix":"10.1371","volume":"15","author":[{"given":"Myriam V.","family":"Valenzuela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0942-8180","authenticated-orcid":true,"given":"Mirian","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mateos-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gonz\u00e1lez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3598-2548","authenticated-orcid":true,"given":"Adela G.","family":"de la Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"pone.0241780.ref001","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"MH Kyaw","year":"2006","journal-title":"N Engl J Med"},{"issue":"9824","key":"pone.0241780.ref002","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)60588-1","article-title":"Serotype replacement after pneumococcal vaccination","volume":"379","author":"K Mulholland","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"pone.0241780.ref003","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1128\/JCM.01222-15","article-title":"Capsule switching and antimicrobial resistance acquired during repeated Streptococcus pneumoniae pneumonia episodes","volume":"53","author":"B Chang","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"5","key":"pone.0241780.ref004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pedneo.2015.08.012","article-title":"Is pneumococcal serotype replacement impending?","volume":"57","author":"CY Lu","year":"2016","journal-title":"Pediatr Neonatol"},{"issue":"5","key":"pone.0241780.ref005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftu011","article-title":"(2015). Non-encapsulated Streptococcus pneumoniae causes otitis media during single-species infection and during polymicrobial infection with nontypeable Haemophilus influenzae","volume":"73","author":"KA Murrah","year":"2015","journal-title":"Pathog Dis"},{"issue":"2","key":"pone.0241780.ref006","doi-asserted-by":"crossref","first-page":"e01792","DOI":"10.1128\/mBio.01792-15","article-title":"Nonencapsulated Streptococcus pneumoniae: emergence and pathogenesis","volume":"7","author":"LE Keller","year":"2016","journal-title":"MBio"},{"key":"pone.0241780.ref007","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1128\/JB.00673-06","article-title":"Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion","volume":"188","author":"M Moscoso","year":"2006","journal-title":"J Bacteriol"},{"key":"pone.0241780.ref008","first-page":"136","volume-title":"The Pneumococcus","author":"DW Crook","year":"2004"},{"key":"pone.0241780.ref009","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fcimb.2014.00194","article-title":"(2015) Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease","volume":"4","author":"Y Chao","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"key":"pone.0241780.ref010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"D Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"pone.0241780.ref011","doi-asserted-by":"crossref","first-page":"e0150949","DOI":"10.1371\/journal.pone.0150949","article-title":"(2016) Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review","volume":"11","author":"CC Ngo","year":"2016","journal-title":"PLoS One"},{"key":"pone.0241780.ref012","doi-asserted-by":"crossref","first-page":"e19844","DOI":"10.1371\/journal.pone.0019844","article-title":"Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease","volume":"6","author":"C Trappetti","journal-title":"PLoS One"},{"key":"pone.0241780.ref013","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1128\/JCM.00756-10","article-title":"(2011) Adenoid reservoir for pathogenic biofilm bacteria","volume":"49","author":"L Nistico","year":"2011","journal-title":"J Clin Microbiol"},{"key":"pone.0241780.ref014","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/01.mlg.0000221954.05467.54","article-title":"Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis","volume":"116","author":"AR Sanderson","year":"2006","journal-title":"Laryngoscope"},{"key":"pone.0241780.ref015","doi-asserted-by":"crossref","first-page":"e1001044","DOI":"10.1371\/journal.ppat.1001044","article-title":"The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms","volume":"6","author":"CJ Sanchez","year":"2010","journal-title":"PLoS Pathog"},{"key":"pone.0241780.ref016","first-page":"107","article-title":"Multidrug tolerance of biofilms and persister cells","volume":"322","author":"K Lewis","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"pone.0241780.ref017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"N Hoiby","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"pone.0241780.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijos.2014.65","article-title":"Strategies for combating bacterial biofilm infections","volume":"7","author":"H Wu","year":"2014","journal-title":"Int J Oral Sci"},{"issue":"3","key":"pone.0241780.ref019","doi-asserted-by":"crossref","first-page":"e59925","DOI":"10.1371\/journal.pone.0059925","article-title":"Mucociliary clearance defects in a murine in vitro model of pneumococcal airway infection","volume":"8","author":"M Fliegauf","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 6","key":"pone.0241780.ref020","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2014full version","volume":"17","author":"M Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"pone.0241780.ref021","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"LA Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"pone.0241780.ref022","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1742-1241.2009.02239.x","article-title":"(2010) Fluoroquinolones in the management of community-acquired pneumonia","volume":"64","author":"TE Albertson","year":"2010","journal-title":"Int J Clin Pract"},{"key":"pone.0241780.ref023","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1093\/nar\/gkq106","article-title":"The genome of Streptococcus pneumoniae is organized in topology reacting gene clusters","volume":"38","author":"MJ Ferr\u00e1ndiz","year":"2010","journal-title":"Nucl Acids Res"},{"key":"pone.0241780.ref024","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.40.10.2252","article-title":"ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype","volume":"40","author":"R Mu\u00f1oz","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref025","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/AAC.40.12.2760","article-title":"High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA","volume":"40","author":"C Janoir","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref026","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3201\/eid1506.080684","article-title":"Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain","volume":"15","author":"AG De la Campa","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"pone.0241780.ref027","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1128\/AAC.02669-13","article-title":"Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006","volume":"58","author":"A Domenech","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref028","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10096-007-0321-5","article-title":"Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae","volume":"26","author":"S Riedel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pone.0241780.ref029","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijantimicag.2009.02.002","article-title":"Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997\u20132006","volume":"34","author":"HJ Adam","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"pone.0241780.ref030","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.00139-07","article-title":"Longitudinal tracking of fluoroquinolone resistance and its determinants in penicillin-susceptible and-nonsusceptible Streptococcus pneumoniae in Hong Kong, 2000 to 2005","author":"M Ip","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref031","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/nar\/gkn936","article-title":"Bacterial topoisomerase I as a target for discovery of antibacterial compounds","volume":"373","author":"YC Tse-Dinh","year":"2009","journal-title":"Nucl Acids Res"},{"key":"pone.0241780.ref032","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/jac\/dkl556","article-title":"Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I","volume":"59","author":"B Cheng","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"pone.0241780.ref033","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1074\/jbc.M110.148148","article-title":"New Alkaloid Antibiotics That Target the DNA Topoisomerase I of Streptococcus pneumoniae","volume":"286","author":"MT Garc\u00eda","year":"2011","journal-title":"J Biol Chem"},{"key":"pone.0241780.ref034","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3389\/fmicb.2018.01659","article-title":"2018. Boldine-derived alkaloids inhibit the activity of DNA topoisomerase I and growth of Mycobacterium tuberculosis","volume":"9","author":"MT Garc\u00eda","year":"2018","journal-title":"Front Microbiol"},{"key":"pone.0241780.ref035","first-page":"7292","article-title":"An increase in negative supercoiling in bacteria reveals topology-reacting gene clusters and a homeostatic response mediated by the DNA topoisomerase I gene","volume":"44","author":"MJ Ferr\u00e1ndiz","year":"2016","journal-title":"Nucl Acids Res"},{"key":"pone.0241780.ref036","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/AAC.00731-07","article-title":"2008. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes","volume":"52","author":"L Balsalobre","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref037","unstructured":"Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing. 2017. Supplement M100-S27."},{"key":"pone.0241780.ref038","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0022-2836(86)90026-4","article-title":"Identification and analysis of genes for tetracycline resistance and replication functions in the broad-host-range plasmid pLS1","volume":"192","author":"SA Lacks","year":"1986","journal-title":"J Mol Biol"},{"key":"pone.0241780.ref039","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2958.1998.00797.x","article-title":"Initiation of biofilms formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signaling pathways: a genetic analysis","volume":"28","author":"GA O\u2019Toole","year":"1998","journal-title":"Mol Microbiol"},{"key":"pone.0241780.ref040","doi-asserted-by":"crossref","first-page":"e01992","DOI":"10.1128\/AAC.01992-16","article-title":"N-acetyl-L-cysteine and cysteamine as new strategies against mixed biofilms of nonencapsulated Streptococcus pneumoniae and nontypeable Haemophilus influenzae","volume":"61","author":"M Domenech","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0241780.ref041","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/jac\/31.6.881","article-title":"Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem","volume":"31","author":"I Odenholt-Tornqvist","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"pone.0241780.ref042","first-page":"157","article-title":"The postantibiotic effect of amoxicillin\/clavulanic acid on Streptococcus pneumoniae strains of different serotypes and penicillin sensitivity","volume":"11","author":"Y Garc\u00eda","year":"1998","journal-title":"Rev Esp Quimioter"},{"key":"pone.0241780.ref043","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.femsec.2004.06.010","article-title":"Exploring the physiological state of continental antarctic endolithic microorganisms by microscopy","volume":"50","author":"AJ De los R\u0131os","year":"2004","journal-title":"FEMS Microbiol Ecol"},{"issue":"Suppl. S1","key":"pone.0241780.ref044","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12551-016-0238-2","article-title":"DNA supercoiling is a fundamental regulatory principle in the control of bacterial gene expression","volume":"8","author":"C.J. Dorman","year":"2016","journal-title":"Biophys. Rev"},{"key":"pone.0241780.ref045","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/AAC.00783-10","article-title":"Nonoptimal DNA topoisomerases allow maintenance of supercoiling levels and improve fitness of Streptococcus pneumoniae","volume":"55","author":"L Balsalobre","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"pone.0241780.ref046","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00003495-199958002-00005","article-title":"Activity of newer fluoroquinolones in vitro against Gram-positive bacteria","volume":"58","author":"GM Eliopoulos","year":"1999","journal-title":"Drugs"},{"key":"pone.0241780.ref047","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jac\/47.6.811","article-title":"(2001). Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae","volume":"47","author":"PD Lister","year":"2001","journal-title":"J Antimicrobial Chemotherapy"},{"key":"pone.0241780.ref048","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/AAC.50.1.210-219.2006","article-title":"Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia","volume":"50","author":"KM Olsen","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"pone.0241780.ref049","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/314054","article-title":"In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program","volume":"31","author":"RN Jones","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"pone.0241780.ref050","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/314057","article-title":"Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae","volume":"31","author":"PC Appelbaum","year":"2000","journal-title":"Clin Infect Dis"},{"key":"pone.0241780.ref051","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2007.06.029","article-title":"Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis","volume":"30","author":"S Roveta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"pone.0241780.ref052","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diagmicrobio.2010.03.016","article-title":"Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-L-cysteine, amoxicillin, erythromycin, and levofloxacin","volume":"67","author":"G Del Prado","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pone.0241780.ref053","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1128\/AAC.01858-13","article-title":"Antibiotic activity against naive and induced Streptococcus pneumoniae biofilms in an in vitro pharmacodynamic model","volume":"58","author":"NM Vandevelde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref054","first-page":"5217","article-title":"Antibacterial activity and mechanism of berberine against Streptococcus agalactiae","volume":"8","author":"L Peng","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"pone.0241780.ref055","article-title":"Composition Analysis and inhibitory effect of Sterculia lychnophora against biofilm formation by Streptococcus mutans","volume":"8163150","author":"Y Yang","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"pone.0241780.ref056","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1517\/13543784.13.9.1159","article-title":"Lipopeptides, focusing on daptomycin, for the treatment of Gram\u2010positive infections","volume":"13","author":"I Eisenstein","year":"2004","journal-title":"Expert Opin Invest Drugs"},{"issue":"1","key":"pone.0241780.ref057","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.44.1.186-189.2000","article-title":"Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria","volume":"44","author":"SK Spangler","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref058","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1128\/AAC.42.5.1253","article-title":"Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci","volume":"42","author":"SK Spangler","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 2","key":"pone.0241780.ref059","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/43.suppl_2.43","article-title":"Bactericidal properties of moxifloxacin and postantibiotic effect","volume":"43","author":"FJ Boswell","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"pone.0241780.ref060","doi-asserted-by":"crossref","first-page":"e00737","DOI":"10.1128\/AAC.00737-19","article-title":"Reactive oxygen species production is a major factor directing the postantibiotic effect of fluoroquinolones in Streptococcus pneumoniae","volume":"63","author":"MT Garc\u00eda","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref061","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/jac\/dkr281","article-title":"Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model","volume":"66","author":"R Cremades","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"pone.0241780.ref062","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/ijms20051116","article-title":"Regulatory Effect of DNA Topoisomerase I on T3SS Activity, Antibiotic Susceptibility and Quorum-Sensing-Independent Pyocyanin Synthesis in Pseudomonas aeruginosa","volume":"20","author":"Y Rong","year":"2019","journal-title":"Int J Mol Science"},{"key":"pone.0241780.ref063","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4142\/jvs.2018.19.6.808","article-title":"Combination of berberine and ciprofloxacin reduces multi-resistant Salmonella strain biofilm formation by depressing mRNA expressions of luxS, rpoE, and ompR","volume":"19","author":"C Shi","year":"2018","journal-title":"J Vet Sci"},{"key":"pone.0241780.ref064","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11908-019-0657-x","article-title":"Biofilm formations in pediatric respiratory tract infection part 2: mucosal biofilm formation by respiratory pathogens and current and future therapeutic strategies to inhibit biofilm formation or eradicate established biofilm","volume":"21","author":"DL Hamilos","year":"2019","journal-title":"Curr Infect Dis Rep"},{"key":"pone.0241780.ref065","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1128\/AAC.01466-07","article-title":"Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains","volume":"52","author":"S Hoshi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0241780.ref066","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1128\/AAC.00724-06","article-title":"Postantibiotic effect of ceftobiprole against 12 Gram-positive organisms","volume":"50","author":"GA Pankuch","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T19:01:04Z","timestamp":1604430064000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0241780"}},"subtitle":[],"editor":[{"given":"Massimiliano","family":"Galdiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":66,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0241780","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]}}}